12% of individuals receiving cardiac device implants develop persistent opioid use, according to a Penn Medicine study.
All comments eligible for publication in Daily Pennsylvanian, Inc. publications.
12% of individuals receiving cardiac device implants develop persistent opioid use, according to a Penn Medicine study.
All comments eligible for publication in Daily Pennsylvanian, Inc. publications.